Microscopic polyangiitis (MPA) is a rare and severe form of systemic necrotizing vasculitis associated with myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody (ANCA). We previously reported significant association of HLA-DRB1*0901 with MPA. To define the susceptibility loci within the HLA region, we determined the genotypes of HLA-DQB1, DPB1, B and C in 50 patients with MPA and 77 unrelated Japanese controls. In addition to HLA-DRB1*0901, significant association of DQB1*0303 (allele carrier frequencies 50% in MPA, 29.9% in controls, odds ratio 2.35, P ¼ 0.017) was detected. These alleles were in strong linkage disequilibrium (D 0 ¼ 0.95, r 2 ¼ 0.82). Increased frequency was also observed for DPB1*0201, B*15111 and Cw*0303, which was at least partly accounted for by linkage disequilibrium with DRB1*0901 and DQB1*0303. These results indicate that DRB1*0901-DQB1*0303 haplotype represents the primary genetic risk for MPA within the HLA region in Japanese, and provides the basis that future functional studies on the role of HLA in MPA should target DR9, DQ9 and DR53 proteins encoded by this haplotype.
Introduction
Microscopic polyangiitis (MPA) is a rare form of systemic necrotizing vasculitis, and the patients often present with severe manifestations such as rapidly progressive glomerulonephritis, pulmonary hemorrhage and interstitial pneumonitis. MPA is strongly associated with myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibodies (ANCA). Together with other conditions associated with ANCA with specificity to MPO, proteinase 3 (PR3) or other antigens, MPA constitutes a condition collectively called ANCA-associated vasculitis (AAV). 1 Although the etiology of AAV is poorly understood, substantial difference in the incidence among populations 2 and sporadic reports of multiplex families 3 suggest a role of genetic predisposition. With respect to MPO-ANCA associated vasculitis, previous studies reported association of HLA [4] [5] [6] and non-HLA genes, 7-10 although many of them have not been confirmed by independent studies.
In the previous study, we conducted the first multicenter study on the genetic background of AAV in Japan, and demonstrated significant association of HLA-DRB1*0901 with MPA. 11 Since HLA-DRB1*0901 is a common allele in Asian populations but rare in other populations, it was suggested that such a difference in the genetic background may be related to apparently higher prevalence of MPA in Japan as compared with Wegener's granulomatosis, which is more frequent in Caucasian populations. 2 Owing to the extensive linkage disequilibrium (LD) in the HLA region, statistical association with HLA-DRB1*0901 does not necessarily mean that HLA-DRB1*0901 molecule is involved in the pathogenesis of MPA. In this study, we made an attempt to narrow down the region that confers susceptibility to MPA in Japanese.
Results and discussion
In view of the linkage disequilibrium structure of HLA region, allele typing was carried out for DQB1, DPB1, B and C loci on 50 patients with MPA (19 men, 31 women, mean age7s.d. 66.1711.4 years) and 77 unrelated healthy Japanese controls (46 men, 31 women, 25.975.6 years). Incidence of MPA in males and females appears to be approximately similar in Caucasians; 11, 12 however, a nationwide study in Japan reported a female preponderance ANCA-associated vasculitis (male : female 1 : 1.8), among which MPA was most prevalent. 13 Diagnosis of MPA was based on the Japanese criteria.
14 All patients were positive for MPO-ANCA, and the diagnosis of most patients were confirmed with biopsy. The detailed explanations of the Japanese criteria and the patients' characteristics are previously described.
14 This study was reviewed and approved by the Research Ethics Committee of the University of Tokyo. Table 1 lists the allele that showed an increase in MPA in each locus. HLA-DQB1*0303 demonstrated statistically significant association as strong as HLA-DRB1*0901. HLA-DQB1*0303 and DRB1*0901 have been shown to be in strong LD, 15, 16 which was confirmed in our control subjects (D 0 ¼ 0.95, r 2 ¼ 0.82). A tendency of increase was also observed for HLA-DPB1*0201, B*15111 and Cw*0303. Among these alleles, the frequency of B*15111 barely reached statistical significance, although the frequencies were low both in the patients and controls.
As the latter alleles have been also shown to be in LD with HLA-DRB1*0901 in Japanese, 15, 16 two-locus analysis was performed between each allele and HLA-DRB1*0901, to distinguish the alleles directly associated with MPA and those that reflect LD with such alleles.
As shown in Table 2A , due to the strong LD between HLA-DRB1*0901 and DQB1*0303, the the numbers of the subjects carrying only one of them (group b and c) were small; thus, the effects of these alleles could not be separated. Independent contribution of Cw*0303 was excluded (Table 2D , group c), and that of DPB1*0201 seemed to be at best marginal (Table 2B , group c).
HLA-B*15111 is one of the alleles coding for serological specificity of HLA-B75. This rare allele (one carrier in 77 controls, Table 1a ) was accumulated in MPA (four carriers, one of whom was homozygous). Four of five carriers of B*15111 including the homozygote possessed DRB1*0901, suggesting that B*15111 is encoded on one of the haplotypes carrying DRB1*0901. Interestingly, one patient was positive for B*15111 in the absence of DRB1*0901 (Table 2C , group c). On the other hand, other HLA-B alleles in LD with DRB1*0901 such as B*4002 and B*4006 15, 16 were not increased in MPA (allele carrier frequencies of B*4002: 14.0% in MPA, 10.4% in controls, B*4006: 10.0% in MPA, 11.7% in controls). These results could possibly suggest that B*15111 itself or another gene in linkage disequilibrium with it might have a contribution independent of DRB1*0901.
TNF gene coding for TNFa is an obvious functional candidate. Although À308 and À238 SNPs in the promoter region of TNFa are both rare, SNPs at À1031, À863 and À857 are common in Japanese. 17 In our subjects, all haplotypes carrying B*15111 were found to encode the major haplotype of TNFa promoter (À1031T, À863C, À857C, TNFA-U01 haplotype). 17 This haplotype was present in 94% of MPA and 87.5% in the controls, which difference did not reach statistical significance, 14 suggesting that the increase of HLA-B*15111 was not caused by direct association of TNF promoter. Thus, possible controbution of HLA-B*15111 should be examined in the future by large-scale studies.
Our present observations indicate that HLA-DRB1*0901-DQB1*0303 haplotype represents the major genetic risk for MPA. These alleles encode DR9 and DQ9 proteins, respectively. Owing to the strong linkage disequilibrium, it is impossible to determine which allele product is functionally relevant in the development of MPA. Furthermore, HLA-DR9, DR4 and DR7 alleles form the DR53 group haplotype, on which DRB4 gene that encode DR53 protein is present. Although alleles that belong to DR4 or DR7 was not increased in the Japanese MPA, 14 increase of DR4 was reported in Caucasian AAV patients, 4, 5 raising the possibility that DRB4 gene product (HLA-DR53 protein) may possibly be funtionally involved in the pathogenesis.
In conclusion, our findings demonstrated that HLA-DRB1*0901-DQB1*0303 haplotype represents the major genetic contribution in the HLA region in Japanese. Owing to the rarity of MPA, these results should be confirmed by independent studies in the Asian populations, because of the low frequency of this haplotype in other populations. Nevertheless, our observations HLA-Cw allele typing was unsuccessful in one control subject; therefore, total number of controls was 76 in the comparison of HLA-Cw.
HLA-class II haplotype in microscopic polyangiitis N Tsuchiya et al strongly suggest that future studies on the role of HLA in the pathogenesis of MPA should target not only HLA-DR9, but also DQ9 and DR53 proteins. Alleles that were increased in MPA in each locus was analyzed for the contribution independent of DRB1*0901. In each comparison, group d lacking both DRB1*0901 and the allele of interest was used as a reference. When any one of the variables contained 0, OR and 95% CI were calculated by adding 0.5 to all variables.
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